Champions Oncology CSBR
NASDAQ CSBR
$4.79 -0.11 (-2.24%)
As of: Oct 14, 2026 · 1:42 PM EDT

Champions Oncology (CSBR) Capital Leases (2018)

Updated

Champions Oncology (CSBR) recorded Capital Leases of $95,000 in fiscal Q2 2019 (quarter ended Oct 31, 2018), down 35.8% from the prior quarter.

Analysis

Champions Oncology (CSBR) Capital Leases (2018) Analysis & Trends

At the end of FY2018 (ended Apr 30, 2018), Champions Oncology reported Capital Leases of $17,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.47 Bn 35.18 Bn 1.44 Bn
2 Medpace Holdings 17.38 Bn 15.44 Bn 201.64 Mn
3 Charles River Laboratories International 14.51 Bn 13.70 Bn 363.37 Mn
4 Icon 13.19 Bn 10.30 Bn 479.29 Mn
5 Fortrea Holdings 2.02 Bn 1.39 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 711.74 Mn -50.34 Mn 18.44 Mn
7 Evotec SE 504.32 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 64.47 Mn 28.12 Mn 1.61 Mn
10 Natural Alternatives International 6.84 Mn -21.24 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2018 95,000.00
Jul 31, 2018 148,000.00
Apr 30, 2018 17,000.00
API Access

Champions Oncology Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=CSBR&period=max&api_key=YOUR_API_KEY